Stock Price
15.66
Daily Change
-0.18 -1.14%
Monthly
-2.06%
Yearly
-16.30%
Q1 Forecast
14.69

Adma Biologics reported $0.15 in EPS Earnings Per Share for its fiscal quarter ending in September of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2027Q1 Mar/2026 0.19 0.12 May/13 2026




Eps Change Date
Adma Biologics USD 0.15 0.01 Sep/2025
Alnylam Pharmaceuticals USD 1.25 1.65 Dec/2025
BioCryst Pharmaceuticals USD 1.17 1.1 Dec/2025
Minerva Neurosciences USD -0.56 3.53 Dec/2024
Novavax USD 0.13 0.59 Dec/2025
Omeros USD -1.12 0.37 Jun/2024
Takeda JPY 65.74 73.57 Dec/2025